Deka Bank Deutsche Girozentrale Ultragenyx Pharmaceutical Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 57,000 shares of RARE stock, worth $2.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

57,000

Previous 57,000 -0.0%

Holding current value

$2.56 Million

Previous $2.36 Million 31.09%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$31.73 - $49.19 $539,410 - $836,230	17,000 Added 42.5%	57,000 $2.75 Million
Q2 2023 Jul 25, 2023	BUY	$37.35 - $52.15 $373,500 - $521,500	10,000 Added 33.33%	40,000 $1.87 Million
Q3 2022 Nov 02, 2022	SELL	$39.96 - $66.14 $413,985 - $685,210	-10,360 Reduced 25.67%	30,000 $1.21 Million
Q2 2022 Aug 03, 2022	SELL	$45.8 - $85.4 $45,800 - $85,400	-1,000 Reduced 2.42%	40,360 $2.41 Million
Q4 2021 Feb 02, 2022	BUY	$73.71 - $87.86 $475,429 - $566,697	6,450 Added 18.48%	41,360 $3.43 Million
Q3 2021 Oct 22, 2021	BUY	$77.92 - $102.4 $1.4 Million - $1.84 Million	18,000 Added 106.45%	34,910 $3.01 Million
Q4 2020 Mar 12, 2021	SELL	$84.4 - $177.39 $129,976 - $273,180	-1,540 Reduced 8.35%	16,910 $2.48 Million
Q3 2020 Oct 29, 2020	BUY	$72.98 - $90.0 $1.35 Million - $1.66 Million	18,450 New	18,450 $1.56 Million
Q4 2019 Feb 04, 2020	SELL	$36.08 - $45.83 $911,020 - $1.16 Million	-25,250 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $2.45 Million - $3.64 Million	-57,750 Reduced 69.58%	25,250 $1.07 Million
Q2 2019 Aug 01, 2019	BUY	$54.93 - $74.36 $4.56 Million - $6.17 Million	83,000 New	83,000 $5.15 Million
Q1 2019 May 10, 2019	SELL	$39.87 - $69.36 $797,400 - $1.39 Million	-20,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$38.89 - $77.3 $777,800 - $1.55 Million	20,000 New	20,000 $840,000
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $1.99 Million - $3.49 Million	-40,920 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$44.33 - $58.52 $780,208 - $1.03 Million	17,600 Added 75.47%	40,920 $2.06 Million
Q3 2017 Nov 06, 2017	BUY	$49.79 - $66.32 $1.16 Million - $1.55 Million	23,320	23,320 $1.43 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Ultragenyx Pharmaceutical Inc. Transaction History